Adhera Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2012 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Adhera Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2012 to Q3 2023.
  • Adhera Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 4.3M shares, a 36.2% increase year-over-year.
  • Adhera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.31M shares, a 252% increase from 2021.
  • Adhera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 655K shares.
  • Adhera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2019 was 10.8M shares, a 0.02% increase from 2018.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 4.3M +1.14M +36.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 3.46M +2.32M +204% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 3.18M +2.32M +270% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 2.31M +1.65M +252% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 3.16M +2.51M +387% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 1.14M -10.5M -90.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 859K -10.3M -92.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 655K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 649K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 11.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 11.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2016 29.8K +3.3K +12.5% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-21
Q2 2016 29.6K +3.59K +13.8% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-15
Q1 2016 28.4M +2.77M +10.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-16
Q4 2015 26.3M +1.67M +6.77% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 26.5K -25.6M -99.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 26K -25.6M -99.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 25.6M +4.19M +19.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 24.6M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 25.7M +8.73M +51.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 25.6M +8.7M +51.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 21.4M +4.51M +26.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 16.9M +2.63M +18.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 16.9M +16.9M +138497% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-19
Q1 2013 16.9M +6.24M +58.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-19
Q3 2012 14.3M Jul 1, 2012 Sep 30, 2012 10-Q 2014-08-07
Q2 2012 12.2K* Mar 31, 2012 Jun 30, 2012 10-Q 2014-08-07
Q1 2012 10.7M Jan 1, 2012 Mar 31, 2012 10-Q 2014-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.